10 Result(s)

Article

Visceral adiposity and inflammatory bowel disease

Rates of obesity are increasing worldwide, as is the incidence of inflammatory bowel disease (IBD). Obesity is now considered an inflammatory state. Visceral adiposity in particular may be associated with a mo...

Catherine R. Rowan, John McManus… in International Journal of Colorectal Disease (2021)

Article

The optimal management of anti-drug antibodies to infliximab and identification of anti-drug antibody values for clinical outcomes in patients with inflammatory bowel disease

Secondary loss of response (LOR) to infliximab (IFX) commonly occurs. One cause is the development of anti-drug antibodies (ADAs). Evidence regarding the optimal management of ADAs is lacking. We aim to identi...

Neasa Mc Gettigan, Aman Shah Afridi… in International Journal of Colorectal Disease (2021)

Article

Assessment of the value of gastroenterologists’ activity in the outpatient setting: applying the “Moneyball” approach to clinical care

With the emergence of alternative payment systems replacing the traditional funding models, the value of physician activity is scrutinized more closely. Attempts have been made to quantify the value of endosco...

Gavin C. Harewood, Carthage Moran… in Irish Journal of Medical Science (1971 -) (2019)

Article

Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA

Anti-TNF therapies have revolutionized the treatment of autoimmune inflammatory conditions. Paradoxical treatment with these agents is associated with the development of de novo autoimmune diseases. Less well ...

Aoibhlinn O’Toole, Matthew Lucci, Joshua Korzenik in Digestive Diseases and Sciences (2016)

Article

Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis

Inflammatory bowel disease may place women at greater risk of adverse pregnancy outcomes.

Aoibhlinn O’Toole, Ogochukwu Nwanne, Tracy Tomlinson in Digestive Diseases and Sciences (2015)

Article

Optimizing Biologic Agents in Ulcerative Colitis and Crohn’s Disease

The goals of therapy in inflammatory bowel disease (IBD) are the induction and maintenance of clinical and biological remission. Mucosal healing is desirable to prevent complications and reduce the need for su...

Aoibhlinn O’Toole, Alan C. Moss in Current Gastroenterology Reports (2015)

Article

Environmental Triggers for IBD

The fundamental elucidation of how environmental influences provoke the initiation of disease as well as flares of inflammatory bowel disease (IBD) remains incomplete. The current understanding of these diseas...

Aoibhlinn O’Toole, Joshua Korzenik in Current Gastroenterology Reports (2014)

Article

Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population

Many aspects of microscopic colitis remain poorly understood. Our aim was to report a single centre experience with this condition.

Aoibhlinn O’Toole, Alan Coss… in International Journal of Colorectal Disease (2014)

Article

Appropriateness of Laboratory Testing in Inflammatory Bowel Disease Inpatients: An Opportunity to Reduce Unnecessary Healthcare Costs

Aoibhlinn O’Toole, Gavin C. Harewood in Digestive Diseases and Sciences (2014)